Vir Bio Ownership | Who Owns Vir Bio?

Overview Forecast RevenueFinancials Chart Transcripts

Vir Bio Ownership Summary

Vir Bio is owned by 100.30% institutional investors, 6.57% insiders. Blackrock funding, inc. /de is the largest institutional shareholder, holding 14.03% of VIR shares. iShares Core S&P Small-Cap ETF is the top mutual fund, with 4.37% of its assets in Vir Bio shares.

VIR Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Vir Bio	100.30%	6.57%	-6.87%
Sector	Healthcare Stocks	244.37%	12.11%	-156.48%
Industry	Biotech Stocks	379.01%	11.75%	-290.76%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Blackrock funding, inc. /de	20.68M	14.03%	$210.71M
Blackrock	16.43M	12.15%	$146.26M
Vanguard group	12.55M	9.03%	$75.67M
Arch venture management	12.69M	8.61%	$129.35M
Sb investment advisers (uk)	10.95M	7.43%	$111.56M
State street	9.96M	6.76%	$101.53M
Gsk	8.55M	5.80%	$87.13M
Vanguard capital management	6.39M	4.34%	$65.10M
Point72 asset management	5.67M	3.85%	$57.74M
Geode capital management	3.35M	2.27%	$34.12M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Bill & melinda gates foundation	1.56M	23.22%	$13.88M
Gsk	8.55M	14.47%	$87.13M
Arch venture management	12.69M	11.76%	$129.35M
Superstring capital management lp	853.68K	5.49%	$8.70M
Alta partners management	509.92K	4.08%	$5.20M
Sio capital management	1.08M	1.81%	$10.96M
Sb investment advisers (uk)	10.95M	1.46%	$111.56M
Boxer capital management	1.87M	1.43%	$19.01M
Adar1 capital management	2.46M	1.15%	$25.03M
Saturn v capital management	770.64K	1.13%	$7.85M

Top Buyers

Holder	Shares	% Assets	Change
Point72 asset management	5.67M	0.06%	3.71M
State street	9.96M	0.00%	2.82M
Blackrock funding, inc. /de	20.68M	0.00%	2.68M
Sixth street partners management company	1.32M	0.00%	1.32M
Savvy advisors	1.04M	0.23%	1.04M

Top Sellers

Holder	Shares	% Assets	Change
Baillie gifford	-	-	-2.38M
Orbimed advisors	-	-	-2.38M
Abrdn	-	-	-1.39M
Balyasny asset management	-	-	-1.37M
Jacobs levy equity management	136.34K	0.01%	-1.31M

New Positions

Holder	Shares	% Assets	Change	Value
Sixth street partners management company	1.32M	0.00%	1.32M	$13.48M
Savvy advisors	1.04M	0.23%	1.04M	$10.60M
Saturn v capital management	770.64K	1.13%	770.64K	$7.85M
Weiss asset management lp	555.54K	0.06%	555.54K	$5.66M
Birchview capital, lp	220.00K	1.05%	220.00K	$2.24M

Sold Out

Holder	Change
Aster capital management (difc)	-1.00
Dinuzzo private wealth	-6.00
Mendota financial group	-6.00
Flagship harbor advisors	-14.00
Abound wealth management	-16.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2026	244	-6.87%	147,793,174	5.96%	100	1.12%	127	-32.45%	75	78.57%
Mar 31, 2026	254	13.39%	124,391,567	7.66%	89	1.29%	183	92.63%	40	-51.81%
Dec 31, 2025	62	-72.20%	17,963,701	-83.21%	12	0.22%	21	-76.14%	27	-66.25%
Sep 30, 2025	79	-64.73%	21,507,831	-80.60%	15	0.24%	31	-70.19%	36	-41.94%
Jun 30, 2025	221	-6.75%	110,948,270	19.67%	80	1.76%	102	-18.40%	62	-11.43%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
iShares Core S&P Small-Cap ETF	7.40M	4.37%	5.10K
State Street® SPDR® S&P® Biotech ETF	4.87M	2.88%	11.18K
Vanguard Total Stock Mkt Idx Inv	4.85M	2.87%	871.20K
Vanguard Morn Total Stk Mkt Idx Investor	4.85M	2.87%	871.20K
Vanguard MStar Total Stk Mkt Idx Invest	4.85M	2.86%	-
Scottish Mortgage Ord	3.80M	2.78%	-
Vanguard US Total Market Shares ETF	3.46M	2.52%	-
Vanguard Small Cap Index	3.49M	2.06%	8.64K
iShares Russell 2000 ETF	3.09M	1.82%	-54.82K
Vanguard Morn Small Cap Growth Index Inv	2.02M	1.20%	391.90K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Jun 01, 2026	Napolitano Janet	-	Sell	$30.24K
Jun 01, 2026	Sabatini Brent	SVP, Chief Accounting Officer	Sell	$3.58K
May 01, 2026	SATO VICKI L	-	Sell	$221.03K
Apr 06, 2026	De Backer Marianne	President and CEO	Sell	$664.35K
Apr 01, 2026	SATO VICKI L	-	Sell	$199.62K

Insider Transactions Trends

Date	Buy	Sell
2026 Q3	-	-
2026 Q2	-	5
2026 Q1	-	20
2025 Q4	-	27
2025 Q3	-	5

VIR Ownership FAQ

Who Owns Vir Bio?

Vir Bio shareholders are primarily institutional investors at 100.30%, followed by 6.57% insiders and -6.87% retail investors. The average institutional ownership in Vir Bio's industry, Biotech Stocks , is 379.01%, which Vir Bio falls below.

Who owns the most shares of Vir Bio?

Vir Bio’s largest shareholders are Blackrock funding, inc. /de (20.68M shares, 14.03%), Blackrock (16.43M shares, 12.15%), and Vanguard group (12.55M shares, 9.03%). Together, they hold 35.21% of Vir Bio’s total shares outstanding.

Does Blackrock own Vir Bio?

Yes, BlackRock owns 12.15% of Vir Bio, totaling 16.43M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 146.26M$. In the last quarter, BlackRock decreased its holdings by -129K shares, a -0.78% change.

Who is Vir Bio’s biggest shareholder by percentage of total assets invested?

Bill & melinda gates foundation is Vir Bio’s biggest shareholder by percentage of total assets invested, with 23.22% of its assets in 1.56M Vir Bio shares, valued at 13.88M$.

Who is the top mutual fund holder of Vir Bio shares?

iShares Core S&P Small-Cap ETF is the top mutual fund holder of Vir Bio shares, with 4.37% of its total shares outstanding invested in 7.4M Vir Bio shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools